Examination Report |
1 | Additional Representation Sheet | 23 Oct 2013 |
1 | TM-1 | 23 Oct 2013 |
10 | Evidence Affidavit Under Rule 46 (TOP) | 01 Feb 2019 |
11 | Annexure -1 under rule 46 | 01 Feb 2019 |
12 | Annexure -1 under rule 46 | 02 Feb 2019 |
12 | Evidence Affidavit Under Rule 46 (TOP) | 02 Feb 2019 |
13 | Annexure -1 under rule 46 | 02 Feb 2019 |
13 | Evidence Affidavit Under Rule 46 (TOP) | 02 Feb 2019 |
14 | Letter | 28 Jul 2020 |
2 | Power of Attorney | 23 Oct 2013 |
3 | Additional Representation Sheet | 23 Oct 2013 |
3 | TM-1 | 23 Oct 2013 |
4 | TM-16 | 20 Feb 2015 |
5 | Reply to Exam Report (MIS-R) | 03 Apr 2015 |
6 | Authorization Letter | 07 Mar 2018 |
7 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 07 Mar 2018 |
8 | Journal Copy | 04 May 2018 |
9 | TM-O(NOTICE OF OPPOSITION) | 11 Jul 2018 |
1 | Hearing Notice (Show Cause) | 5803395 | 2534593 | 01 Feb 2018 |
2 | Tribunal Accepted Notice for : 2616727 | 6015763 | 2611042 | 07 Mar 2018 |
3 | Opposition Notice | 6752318 | 3057707 | 30 Jul 2018 |
4 | Opposition Counter Statement | 7076395 | 3262118 | 01 Oct 2018 |
Stelis was applied on 23 October 2013.
Trademark application was filed by STELIS BIOPHARMA.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Opposed.
Listed application Id of Stelis is 2616727.
Trademark attorney of the Stelis is Altacit Global.
Stelis is a WORD as per IP India data.